In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Axsome Therapeutics Inc (NASDAQ: AXSM) closed at $98.19 in the last session, up 3.79% from day before closing price of $94.60. In other words, the price has increased by $3.79 from its previous closing price. On the day, 0.79 million shares were traded. AXSM stock price reached its highest trading level at $99.32 during the session, while it also had its lowest trading level at $94.25.
Ratios:
We take a closer look at AXSM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.37 and its Current Ratio is at 2.44. In the meantime, Its Debt-to-Equity ratio is 2.07 whereas as Long-Term Debt/Eq ratio is at 2.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on September 03, 2024, initiated with a Overweight rating and assigned the stock a target price of $140.
On August 06, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $95 to $106.
On July 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $130.Needham initiated its Buy rating on July 22, 2024, with a $130 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’24 when Saad Mark E sold 11,016 shares for $91.31 per share. The transaction valued at 1,005,871 led to the insider holds 10,002 shares of the business.
Saad Mark E bought 11,016 shares of AXSM for $1,005,843 on Sep 11 ’24. On Aug 09 ’24, another insider, Jacobson Mark L., who serves as the Chief Operating Officer of the company, sold 47,739 shares for $84.26 each. As a result, the insider received 4,022,488 and left with 5,783 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AXSM now has a Market Capitalization of 4758523392 and an Enterprise Value of 4623479808. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.06 while its Price-to-Book (P/B) ratio in mrq is 51.20. Its current Enterprise Value per Revenue stands at 13.66 whereas that against EBITDA is -18.9.
Stock Price History:
Over the past 52 weeks, AXSM has reached a high of $105.00, while it has fallen to a 52-week low of $58.61. The 50-Day Moving Average of the stock is 8.04%, while the 200-Day Moving Average is calculated to be 18.85%.
Shares Statistics:
According to the various share statistics, AXSM traded on average about 459.99K shares per day over the past 3-months and 751710 shares per day over the past 10 days. A total of 47.35M shares are outstanding, with a floating share count of 39.56M. Insiders hold about 18.37% of the company’s shares, while institutions hold 79.07% stake in the company. Shares short for AXSM as of 1730332800 were 7577624 with a Short Ratio of 16.47, compared to 1727654400 on 7758630. Therefore, it implies a Short% of Shares Outstanding of 7577624 and a Short% of Float of 18.94.
